Cancer Family
Malignant Nervous System Neoplasm
CI-CAN-00000246Explore in graph →
953 active trials7 approved drugs131 evidence items
- NCIt
- C4788
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000246Explore in graph →
Clinical trials
3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (495)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02329002 | SPT Screening in Irradiated Hereditary Retinoblastoma Survivors | unknown | — | 400 | Amsterdam UMC, location VUmcOTHER | 1 | Dec 31, 2014 | clinicaltrials |
| NCT02137928 | Carboplatin Periocular Injection for Retinoblastoma | unknown | Phase 3 | 50 | Sun Yat-sen UniversityOTHER | 1 | Dec 19, 2014 | clinicaltrials |
| NCT01124539 |
| Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma |
| unknown |
| Phase 2 |
| 58 |
| Arno TherapeuticsINDUSTRY |
| 2 |
| Dec 9, 2014 |
| clinicaltrials |
| NCT01899066 | Efficacy Study of Lucentis in the Treatment of Retinoblastoma | unknown | Phase 2 | 20 | Sun Yat-sen UniversityOTHER | 1 | May 13, 2014 | clinicaltrials |
| NCT01943097 | Evaluation of 18F-dopa and 123I-MIBG Uptake in the Patients With Neuroblastoma | unknown | — | 160 | National Taiwan University HospitalOTHER | 1 | Apr 14, 2014 | clinicaltrials |
| NCT02047058 | Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics | unknown | — | 240 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jan 28, 2014 | clinicaltrials |
| NCT00084695 | Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases | unknown | Phase 2 | 25 | Milton S. Hershey Medical CenterOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00101309 | Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma | unknown | Phase 1 | 10 | Milton S. Hershey Medical CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT01986595 | A Pilot Study on ALK Gene Mutations in Neuroblastoma | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Nov 18, 2013 | clinicaltrials |
| NCT01640509 | Synchrotron Radiation to the Treatment of Intracranial Tumors(ESRF) | unknown | Phase 1 / Phase 2 | 50 | University Hospital, GrenobleOTHER | 1 | Nov 11, 2013 | clinicaltrials |
| NCT01818713 | Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases | unknown | Phase 2 | 6 | The Netherlands Cancer InstituteOTHER | 1 | Oct 29, 2013 | clinicaltrials |
| NCT00036712 | Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation | unknown | Phase 2 | 80 | Medical College of WisconsinOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00281905 | Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors | unknown | Phase 2 | 50 | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 20, 2013 | clinicaltrials |
| NCT00349024 | Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer | unknown | N/A | 50 | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 20, 2013 | clinicaltrials |
| NCT00416559 | Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only | unknown | Phase 2 | 140 | Children's Cancer and Leukaemia GroupOTHER | 0 | Sep 20, 2013 | clinicaltrials |
| NCT00003743 | Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation | unknown | Phase 2 | 25 | St. Anna KinderkrebsforschungOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00276731 | Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma | unknown | Phase 3 | — | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 17, 2013 | clinicaltrials |
| NCT00287950 | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma | unknown | N/A | 120 | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 17, 2013 | clinicaltrials |
| NCT00360750 | Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye | unknown | N/A | — | Children's Cancer and Leukaemia GroupOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00392340 | Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma | unknown | Phase 2 | 63 | Children's Cancer and Leukaemia GroupOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00003122 | Surgery in Treating Patients With Neuroblastoma | unknown | Phase 2 | 210 | Societe Internationale d'Oncologie PediatriqueOTHER | 8 | Aug 26, 2013 | clinicaltrials |
| NCT00939965 | Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma | unknown | N/A | 75 | Children's Cancer and Leukaemia GroupOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00024193 | Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma | unknown | Phase 2 | — | Children's Cancer and Leukaemia GroupOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00410631 | Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma | unknown | Phase 3 | 642 | German Society for Pediatric Oncology and Hematology GPOH gGmbHOTHER | 2 | Aug 7, 2013 | clinicaltrials |
| NCT00416676 | Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma | unknown | Phase 3 | 30 | Children's Cancer and Leukaemia GroupOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00417053 | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant | unknown | Phase 3 | — | Children's Cancer and Leukaemia GroupOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT01890278 | Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases | unknown | N/A | 60 | Good Samaritan Hospital Medical Center, New YorkOTHER | 1 | Jul 1, 2013 | clinicaltrials |
| NCT01798771 | Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery(IMAGER) | unknown | N/A | 108 | Johann Wolfgang Goethe University HospitalOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT01777451 | Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in Neurofibromatosis(NEFIMAR) | unknown | — | 30 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT01579253 | Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients | unknown | — | 10 | Ludwig-Maximilians - University of MunichOTHER | 1 | Dec 18, 2012 | clinicaltrials |
| NCT01737346 | Procarbazine and Lomustine in Recurrent Glioblastoma | unknown | Phase 2 | 52 | Incheon St.Mary's HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01656980 | Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma | unknown | Phase 3 | 236 | Shandong Lanjin Pharmaceuticals Co.,LtdINDUSTRY | 1 | Aug 3, 2012 | clinicaltrials |
| NCT01637753 | Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma | unknown | N/A | 212 | Shandong Lanjin Pharmaceuticals Co.,LtdINDUSTRY | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00798148 | 131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma | unknown | Phase 1 / Phase 2 | 10 | Tehran University of Medical SciencesOTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT01525251 | Nurse Case Manager Model on Neuroblastoma Caregiver's Uncertainty(NCMM) | unknown | — | 60 | National Taiwan University HospitalOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01144988 | Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant Glioma(AVIRMA01-09) | unknown | Phase 2 | 35 | Medical University InnsbruckOTHER | 1 | Aug 2, 2011 | clinicaltrials |
| NCT01124240 | Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene(ExCentric) | unknown | Phase 2 | 48 | Northern Sydney and Central Coast Area Health ServiceOTHER | 1 | Jul 26, 2011 | clinicaltrials |
| NCT01373736 | 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors | unknown | Phase 3 | — | Vancouver Coastal HealthOTHER_GOV | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00686387 | Establishment of a Brain and Spinal Tumor Tissue Bank | unknown | — | 70 | Taipei Medical University WanFang HospitalOTHER | 1 | Apr 12, 2011 | clinicaltrials |
| NCT01181193 | Vitamin D for Treatment of Glioblastoma Multiforme | unknown | Phase 1 / Phase 2 | 20 | Soroka University Medical CenterOTHER | 1 | Mar 29, 2011 | clinicaltrials |
| NCT00635557 | Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme | unknown | Phase 1 / Phase 2 | 30 | Myrexis Inc.INDUSTRY | 1 | Mar 25, 2011 | clinicaltrials |
| NCT01317888 | Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas | unknown | N/A | 11 | Drexel UniversityOTHER | 0 | Mar 17, 2011 | clinicaltrials |
| NCT01308632 | Metronomic Temozolamide in Patients With Recurrent Glioblastoma | unknown | Phase 2 / Phase 3 | 30 | Grupo Español de Investigación en NeurooncologíaOTHER | 0 | Mar 4, 2011 | clinicaltrials |
| NCT01156350 | Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma(Rice NK) | unknown | Phase 2 | 10 | University Hospital, Clermont-FerrandOTHER | 1 | Jan 19, 2011 | clinicaltrials |
| NCT01235845 | Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma | unknown | Phase 1 / Phase 2 | 30 | Qingdao UniversityOTHER | 1 | Dec 3, 2010 | clinicaltrials |
| NCT00562419 | CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan | unknown | Phase 2 | 72 | Adnexus, A Bristol-Myers Squibb R&D CompanyINDUSTRY | 1 | Oct 27, 2010 | clinicaltrials |
| NCT00768911 | CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme | unknown | Phase 1 | 30 | Adnexus, A Bristol-Myers Squibb R&D CompanyINDUSTRY | 1 | Oct 27, 2010 | clinicaltrials |
| NCT01208909 | Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI) | unknown | — | 40 | University of ZurichOTHER | 1 | Oct 22, 2010 | clinicaltrials |
| NCT00535379 | SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme(SURGE01-07) | unknown | Phase 2 | 70 | Medical University InnsbruckOTHER | 2 | Aug 30, 2010 | clinicaltrials |
Data updated 22 days agoSource updated Dec 31, 2014source: clinicaltrials